Discovery of Novel Tetrahydropyrido-Pyrazole based Cathepsin S Inhibitors: Implications of Two Dimensional Quantitative Structure Activity Relationship Analysis

نویسندگان

چکیده

The anti-arthritic activity of cathepsin S enzyme has been acknowledged and regarded as an emerging target for the development novel therapeutic agents treatment various autoimmune disorders other inflammatory diseases. Two dimensional-quantitative structure-activity relationships have performed on a series tetrahydropyrido-pyrazole nucleus using TSAR 3.3. Attempts made to derive comprehend correlation between biological (dependent variable) descriptors (independent variables). study was 268 compounds (data set) by division into training test set random selection method. 179 generated final quantitative relationship model with leave-out one row method cross-validation evaluate predictive ability model. most significant n=179, regression coefficient (0.851), (0.725), cross-validated (0.709), standard error (0.349), Fischer statistic value (114.706) developed multiple linear analysis. For partial least squares, statistical significance 0.988 fraction variance explained 0.723 were observed. A comparable squares (0.723) neural (0.731) indicated good internal predictability External validation provided values 0.708 0.706 regressions analysis respectively. Quantitative importance hydrophobic (log P (substituent 1)), topological (kier chi 5 (path) index (whole molecule)), electronic (bond dipole moment 5)) (dipole Z component 1)) Cathepsin inhibitors. This will be effective in designing more potent

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.

CYP51 fulfills an essential requirement for all cells, by catalyzing three sequential mono-oxidations within the cholesterol biosynthesis cascade. Inhibition of fungal CYP51 is used as a therapy for treating fungal infections, whereas inhibition of human CYP51 has been considered as a pharmacological approach to treat dyslipidemia and some forms of cancer. To predict the interaction of inhibito...

متن کامل

Three Dimensional-Quantitative Structure Activity Relationship (3D-QSAR) Analysis Of Human CYP51 Inhibitors

CYP51 fulfills an essential requirement for all cells, by catalyzing three sequential monooxidations within the cholesterol biosynthesis cascade. Inhibition of fungal CYP51 is used as a therapy for treating fungal infections, while inhibition of human CYP51 has been considered as a pharmacological approach to treat dyslipidemia and some forms of cancer. In order to predict the interaction of in...

متن کامل

Discovery of Novel Cathepsin S Inhibitors by Pharmacophore-Based Virtual High-Throughput Screening

The cysteine protease cathepsin S (CatS) is involved in the pathogenesis of autoimmune disorders, atherosclerosis, and obesity. Therefore, it represents a promising pharmacological target for drug development. We generated ligand-based and structure-based pharmacophore models for noncovalent and covalent CatS inhibitors to perform virtual high-throughput screening of chemical databases in order...

متن کامل

Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo.

Specific inhibitors for cathepsin L and cathepsin S have been developed with the help of computer-graphic modeling based on the stereo-structure. The common fragment, N-(L-trans-carbamoyloxyrane-2-carbonyl)-phenylalanine-dimethyla mide, is required for specific inhibition of cathepsin L. Seven novel inhibitors of the cathepsin L inhibitor Katunuma (CLIK) specifically inhibited cathepsin L at a ...

متن کامل

Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.

The dose-limiting toxicity of the highly effective anticancer agent 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (irinotecan; CPT-11) is delayed diarrhea. This is thought to be caused by either bacteria-mediated hydrolysis of the glucuronide conjugate of the active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) or direct conversion of CPT-11 to SN-38 by carboxylesterase...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Indian Journal of Pharmaceutical Sciences

سال: 2022

ISSN: ['0250-474X', '1998-3743']

DOI: https://doi.org/10.36468/pharmaceutical-sciences.1010